Click here for search
Click here for search

Protecting pharmacy compounding—and the patients it serves

As the only pharmacy association whose advocacy focus is solely pharmacy compounding, APC is the leading voice at the federal level — and increasingly in states, too — on a range of issues impacting pharmacy compounders and the patients served by compounded preparations.
Layer_1 (2)
Pharmacy compounding continues to be threatened by ill-conceived regulation, making APC’s role even more important.

We advocate for sensible, science-based regulation and will continue to fight overreach by regulatory agencies that hinders patient access to practitioner-prescribed compounded medications.

AdobeStock_87177302 (1)
image-container (9)
Federal Advocacy Efforts

From compounded hormones to veterinarian-prescribed compounding from pure ingredients, and from the MOU to the USP chapters, here are APC’s current issue priorities.

image-container (8)
State-Level Advocacy

Members-only resources for state-level legislative and regulatory tracking on compounding issues.

Layer_1 (1)

Tell FDA: Nonsense!

Drugmakers have asked FDA to prohibit compounded GLP-1s

Get Involved

There is much you can do to help enhance our advocacy efforts, from regular contact with your representatives in Congress to hosting your representatives in your pharmacy.

Pharmacists’ ability to compound medications from pure ingredients is authorized in federal law and for good reasons: Manufactured drugs don’t come in strengths and dosage forms that are right for everyone, and practitioners need to be able to prescribe customized medication therapy for a patient.

Group 12 (5)
CompPAC: Electing Candidates Who Think Like You
Group 13 (1)-1
OneFund: Fueling APC’s Advocacy